From Name:
From Email:
To Name:
To Email:

Optional Message:


Biogen's good news on aducanumab could 'open the floodgates' for Alzheimer's drugs

from STATNews

One of the many things I’ve learned during four decades of doing research on Alzheimer’s disease is that the work always brings surprises. Biogen’s recent announcement about its experimental Alzheimer’s drug, aducanumab, was a big one. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063